Sie sehen das neue Design von cash. Details
Die klassische Ansicht finden Sie hier
Hält noch jemand diese Aktie?
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2015 before the market opens on Wednesday, October 21, 2015, and will hold a conference call on the same day at 8:30 a.m. EDT.
During the call, the company will discuss its third quarter financial performance, as well as future expectations. To listen, call (877) 201-0168 within the U.S. or (647) 788-4901 outside the U.S.
Thermo Fisher Scientific Completes Acquisition of Alfa Aesar to Significantly Expand Laboratory Chemicals Offering
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has completed its previously announced acquisition of Alfa Aesar, a leading global manufacturer of research chemicals, from Johnson Matthey Plc, for GBP256 million (or approximately $400 million) in cash.
"With the close of the transaction, we now have the opportunity to fully leverage our combined capabilities in laboratory chemicals to drive growth," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. "The addition of Alfa Aesar products to our existing chemicals portfolio offers customers greater access to a broad offering that serves virtually every laboratory application -- from research to production."
Alfa Aesar has approximately 480 employees at key locations in the United Kingdom, United States, Germany, China, South Korea and India. The business generated sales of approximately GBP78 million in 2014 and will be integrated into Thermo Fisher's Laboratory Products and Services Segment.
Thermo Fisher Scientific Inc (NYSE:TMO): The stock price is expected to reach $ 156.09 in the short term. The number of analysts agreeing with this consensus is 11. The higher estimate for the short term price target is at $165 while the lower estimate is at $141.
Thermo Fisher Scientific Inc (NYSE:TMO) has received a short term rating of buy from research analysts at Zacks with a rank of 2. The company has been rated an average of 1.04 by 14 Wall Street Analysts. 13 analysts have added the shares in their list of strong buys. 1 stock experts have also rated a buy.
Many analysts have commented on the company rating. In a research note released to the investors, Leerink Swann maintains its rating on Thermo Fisher Scientific Inc (NYSE:TMO).The analysts at the brokerage house have a current rating of Outperform on the shares. In a recent information released to the investors, Leerink Swann raises the new price target from $141 per share to $149 per share. The rating by the firm was issued on July 23, 2015.
© 1998-2016 / cash
| Impressum |